SCHEMBL4089119

SCHEMBL4089119

O=c1[nH]c(C2C3CC4CC(C3)CC2C4)c(CC(F)(F)F)n1CC1CC1

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRIN1 Q05586 3/20 0.31
GRIN2B Q13224 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4081443 0.80
SCHEMBL4082103 0.78 MEN1 (0.42) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL4083608 0.74 MEN1 (0.40) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL4082455 0.70 MEN1 (0.35) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL4082407 0.62
SCHEMBL4078872 0.60 YTHDF2 (0.39)
SCHEMBL75973 0.59 EPHX2 (0.32) SMN1; SMN2
SCHEMBL1546788 0.57 ALDH1A1 (0.54) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL1943792 0.57 ALDH1A1 (0.54) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL4088862 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2104665-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. Hoffmann-Roche AG (CH) 2009-09-30 EP claimed
WO-2008046758-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO claimed
EP-2104665-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. Hoffmann-Roche AG (CH) 2009-09-30 EP disclosed
WO-2008046758-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO disclosed